Figure 7From: A randomized, double-blind, placebo-controlled trial of calcium acetate on serum phosphorus concentrations in patients with advanced non-dialysis-dependent chronic kidney disease Proportion (%) of patients in, below, or above the target range of serum parathyroid hormone level (70-110 pg/mL) at 12 weeks.Back to article page